ANL 14.34 Decreased By ▼ -0.41 (-2.78%)
ASC 13.95 Decreased By ▼ -0.05 (-0.36%)
ASL 15.10 No Change ▼ 0.00 (0%)
BOP 8.52 Decreased By ▼ -0.08 (-0.93%)
BYCO 6.54 Decreased By ▼ -0.15 (-2.24%)
FCCL 18.80 No Change ▼ 0.00 (0%)
FFBL 26.85 Increased By ▲ 0.35 (1.32%)
FFL 11.00 Decreased By ▼ -0.19 (-1.7%)
FNEL 10.51 Decreased By ▼ -0.38 (-3.49%)
GGGL 16.25 Increased By ▲ 0.55 (3.5%)
GGL 31.50 Decreased By ▼ -0.61 (-1.9%)
HUMNL 6.24 Decreased By ▼ -0.11 (-1.73%)
JSCL 16.89 Decreased By ▼ -0.37 (-2.14%)
KAPCO 33.10 Decreased By ▼ -0.15 (-0.45%)
KEL 3.27 Increased By ▲ 0.04 (1.24%)
MDTL 2.27 No Change ▼ 0.00 (0%)
MLCF 37.10 Increased By ▲ 0.65 (1.78%)
NETSOL 102.80 Increased By ▲ 0.64 (0.63%)
PACE 4.68 Increased By ▲ 0.28 (6.36%)
PAEL 23.15 Decreased By ▼ -0.40 (-1.7%)
PIBTL 7.86 Increased By ▲ 0.16 (2.08%)
POWER 7.05 Increased By ▲ 0.29 (4.29%)
PRL 13.66 Decreased By ▼ -0.27 (-1.94%)
PTC 8.90 Decreased By ▼ -0.17 (-1.87%)
SILK 1.31 Decreased By ▼ -0.04 (-2.96%)
SNGP 41.70 Decreased By ▼ -0.10 (-0.24%)
TELE 16.99 Increased By ▲ 0.06 (0.35%)
TRG 87.75 Decreased By ▼ -2.76 (-3.05%)
UNITY 25.35 Increased By ▲ 0.05 (0.2%)
WTL 2.20 Increased By ▲ 0.05 (2.33%)
BR100 4,671 Increased By ▲ 6.15 (0.13%)
BR30 18,834 Increased By ▲ 159.86 (0.86%)
KSE100 45,369 Increased By ▲ 296.76 (0.66%)
KSE30 17,576 Increased By ▲ 146.24 (0.84%)

Coronavirus
LOW Source: covid.gov.pk
Pakistan Deaths
28,737
924hr
Pakistan Cases
1,285,254
41424hr
0.98% positivity
Sindh
475,820
Punjab
443,185
Balochistan
33,484
Islamabad
107,722
KPK
180,075
Pakistan

AstraZeneca seeks registration of COVID-19 vaccine in Pakistan: report

  • The data of the clinical trials of the Oxford-AstraZeneca vaccine was also shared with the authority.
  • The vaccine has already been approved by British Medicine and Healthcare Products Regulatory Authority.
Updated 14 Jan 2021

British¬Swedish pharmaceutical giant AstraZeneca has sought approval for its coronavirus vaccine from Pakistan.

ARY News citing its sources reported that the company has applied for registration to the Drug Regulatory Authority of Pakistan (DRAP) via Pakistani pharmaceutical company.

The data of the clinical trials of the Oxford-AstraZeneca vaccine was also shared with the authority.

The registration of the vaccines is expected in the ongoing session for the authority, report revealed. The registration board will remain in session until January 15, the publication citing its sources within the Ministry of National Health reported.

After being registered the COVID-19 vaccine could be used in Pakistan.

It is worth to mention here that the vaccine has already been approved by British Medicine and Healthcare Products Regulatory Authority. It said to be effective for people of all age groups and could be stored in home refrigerators.

The DRAP registration board in its current session will also likely to approve registration of China’s Sinopharm COVID-19 vaccine.

Sinopharm had recently sought permission from Pakistan for emergency use of its COVID-19 vaccine in the country.

We love hearing your feedback, please help us improve by answering these few survey questions

Comments

Comments are closed.